Steven Newmark ретвитнул

#ACR24 research on #rheumatoidarthritis patients starting a 1st-line TNF therapy finds:
👉 Most who don’t respond to the treatment at 3 months still don’t respond by 12 months
👉 1 in 4 patients achieving low disease activity/remission at 3 months were no longer at 12 months
@abbvie
cdmcd.co/jP76Zg
English







